#膠質母細胞瘤
Live, measured metrics for the hashtag #膠質母細胞瘤 from the open social web. Every number carries a named source and the time it was fetched. Nothing is estimated.
Own #膠質母細胞瘤
This #name is available to claim. It becomes your portal on the open agent web: this very page, a keyword you rank for by an open public stake, and a verifiable identity for AI agents. Nobody else sells a page like this for every #name.
Day-by-day usage
measured · fosstodon.org (Mastodon public tags API) · fetched 2026-08-26 18:20 UTC0 uses by 0 unique accounts across the window. Real per-day counts, not estimates. Newest bar is today so far.
Related hashtags
measured · fosstodon.org (Mastodon public search API) · fetched 2026-08-26 18:20 UTCNo related tags with measured usage found for #膠質母細胞瘤.
Live pulse
measured · fosstodon.org (Mastodon tag timeline) · fetched 2026-08-26 18:20 UTCEverything below is measured over the latest 2 public posts (spanning ~0 hours).
Posting hours (UTC)
Avg boosts / post: 0
Used together with
Top of the latest posts
World-first experimental cancer treatment paves way for clinical trial | WEHI Link # 腦癌新型免疫療法實驗治療 📌 Summary: 澳洲研究人員發表了一項針對惡性腦癌 (膠質母細胞瘤) 的世界首創實驗性治療方法，已在《自然醫學》期刊發表。此治療由悉尼大學腫瘤學教授 Georgina Long 領導，採用三種免疫檢查點抑制劑的組合，在手術前進行治療，首次在膠質母細胞瘤患者中使用新輔助三重免疫
World-first experimental cancer treatment paves way for clinical trial | WEHI Link📌 Summary: 一項針對侵襲性腦癌的實驗性治療方法近日在《Nature Medicine》發表，為臨牀試驗鋪平了道路。由悉尼大學的醫療腫瘤學家長教授領導的團隊，首次使用新輔助三重免疫療法治療膠質母細胞瘤。這項療法結合三種免疫檢查點抑制劑，在手術前進行，顯示出顯著的免疫反應。該患者目前在接受治療超過18個月後
#膠質母細胞瘤 across platforms
every network with a public tag surfaceFollow #膠質母細胞瘤 straight to each platform’s own tag page. Where a platform publishes open data we measure it above; the rest lock their numbers behind paid APIs, so we link rather than guess.
Every number above is measured from a named public API at the shown fetch time. Nothing is estimated or extrapolated. Platforms that lock their data behind paid APIs are not shown. Agents: the same numbers, as JSON, at /api/hashtags/膠質母細胞瘤